News Sentiment

RIGL sentiment intelligence

Rigel Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors Options RSS feed
Weighted score 52 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 36.81 Week of 31 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Earnings

76/100 classification confidence.

Company focus 50

directly relevant articles

Source quality 6

high-authority source matches

Trend context Trend active

+0.2% over one week, -4.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Empowered Funds LLC Takes Position in Rigel Pharmaceuticals, Inc. $RIGL

Market Reaction

Balanced read

49/100 confidence

News tone and price action are not far from neutral.

Primary event Earnings 76/100 classification
One-week reaction 0.2% Price digesting
Trend fit Trend active -4.9% over four weeks
Fair value 70.3% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 12
Neutral 41
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 50
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
simplywall.st 8
Market source 7
TradingKey 7
Stock Titan 6
TradingView 5
Seeking Alpha 4
MarketBeat 3
Quartr 3

Event Lens

What the news is about

Classified themes
Earnings 29
Market update 22
Analyst action 2
Guidance 2
Deals and strategy 2
Regulatory and legal 1
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-59 of 59
Quartr Direct company coverage

Rigel Pharmaceuticals (RIGL) Q1 2026 earnings summary

Rigel Pharmaceuticals (RIGL) announced total revenues of $58.8 million in Q1 2026, including $54.9 million in net product sales, marking a 26% year-over-year increase. The company maintained profitability with an $8.7 million net income despite higher R&D and SG&A expenses, drive

Tone
Positive 71/100
Event
Earnings
Published
11 Jul 2026 11:10
Source
Quartr
Quartr Direct company coverage

Rigel Pharmaceuticals (RIGL) Corporate presentation Summary

Rigel Pharmaceuticals' corporate presentation outlines its transformational growth strategy, focusing on expanding its commercial business, advancing its pipeline, and in-licensing. The company has grown from one commercial product in 2020 to three by 2025, with a fourth, VEPPANU

Tone
Positive 70/100
Event
Market update
Published
11 Jul 2026 11:10
Source
Quartr
Investing.com Nigeria Direct company coverage

Form 4 Rigel Pharmaceuticals Inc For: 10 July By Investing.com

This article reports on a Form 4 filing by Rigel Pharmaceuticals Inc. for transactions that occurred on July 10th. The filing is a standard regulatory disclosure related to insider trading, though the article does not provide specific details from the form itself. The document si

Tone
Neutral 50/100
Event
Regulatory and legal
Published
11 Jul 2026 01:41
Source
Investing.com Nigeria
Stock Titan Direct company coverage

Rigel Pharmaceuticals (RIGL) CMO receives 24,400-share RSU equity award with 4-year vesting

Rigel Pharmaceuticals' EVP and Chief Medical Officer, Alison L. Hannah, was granted 24,400 Restricted Stock Units (RSUs) which will vest annually over four years, starting July 8, 2027. Following this award and the cancellation of 5,750 RSUs, Ms. Hannah directly holds 35,025 shar

Tone
Neutral 50/100
Event
Market update
Published
11 Jul 2026 01:40
Source
Stock Titan
Quartr Direct company coverage

Rigel Pharmaceuticals (RIGL) Proxy filing Summary

Rigel Pharmaceuticals has issued a proxy filing summarized on April 3, 2026, outlining key proposals for its annual meeting scheduled for May 14, 2026. Shareholders will vote on the election of three directors, amendments to two equity incentive plans to add shares, an advisory v

Tone
Neutral 50/100
Event
Market update
Published
08 Jul 2026 08:39
Source
Quartr